These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19125553)

  • 21. Clopidogrel.
    Orford JL; Fasseas P; Brosh D; Berger PB
    Indian Heart J; 2001; 53(6):788-91. PubMed ID: 11838939
    [No Abstract]   [Full Text] [Related]  

  • 22. Clopidogrel and cardiovascular diseases: recommendations for its correct use.
    Pyrgakis VN; Goudevenos JA
    Hellenic J Cardiol; 2010; 51(1):83-6. PubMed ID: 20118052
    [No Abstract]   [Full Text] [Related]  

  • 23. Cost is not a barrier to implementing clopidogrel pharmacogenetics.
    Cavallari LH; Schumock GT
    Pharmacotherapy; 2012 Apr; 32(4):299-303. PubMed ID: 22461119
    [No Abstract]   [Full Text] [Related]  

  • 24. Clopidogrel and long-term outcomes after drug-eluting stent implantation.
    Falcone EL; Tangri N
    JAMA; 2007 Apr; 297(16):1770; author reply 1770-1. PubMed ID: 17456815
    [No Abstract]   [Full Text] [Related]  

  • 25. Clopidogrel plus aspirin in atrial fibrillation.
    Lee YE; DeZee KJ
    N Engl J Med; 2009 Sep; 361(13):1313-4; author reply 1314-5. PubMed ID: 19780215
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiovascular and Renal Advisory Panel of the FDA.
    Roden DM
    Circulation; 1998 Mar; 97(12):1107. PubMed ID: 9537333
    [No Abstract]   [Full Text] [Related]  

  • 27. Clopidogrel: a review of its use in the prevention of thrombosis.
    Plosker GL; Lyseng-Williamson KA
    Drugs; 2007; 67(4):613-46. PubMed ID: 17352522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clopidogrel: the good, the bad, and the ugly.
    Chow G; Ziegelstein RC
    Am J Cardiovasc Drugs; 2007; 7(3):169-71. PubMed ID: 17610344
    [No Abstract]   [Full Text] [Related]  

  • 29. New antiplatelet agents for cardiovascular disease.
    Chua D; Nishi C
    CMAJ; 2013 Nov; 185(16):1405-11. PubMed ID: 24016786
    [No Abstract]   [Full Text] [Related]  

  • 30. Glycemic control and clopidogrel response.
    Gaborit B; Cuisset T; Frère C; Alessi MC; Dutour A
    Am Heart J; 2010 Jun; 159(6):e35. PubMed ID: 20569701
    [No Abstract]   [Full Text] [Related]  

  • 31. Variable access to clopidogrel in a harmonized EU market.
    Stolk P; Belitser SV; Leufkens HG; Heerdink ER
    Value Health; 2008; 11(5):989-95. PubMed ID: 18489520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifibrinolytics may be cost saving among recent recipients of combined acetylsalicylic acid and clopidogrel who undergo coronary artery bypass graft surgery.
    Ray JG; Hamielec CM
    Can J Cardiol; 2004 Jun; 20(8):829-30. PubMed ID: 15229768
    [No Abstract]   [Full Text] [Related]  

  • 33. Aspirin and clopidogrel resistance: methodological challenges and opportunities.
    Gasparyan AY
    Vasc Health Risk Manag; 2010 Mar; 6():109-12. PubMed ID: 20448796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Appropriateness of clopidogrel use according to current recommendations.
    Fornós-Garrigós A; Orozco-Beltrán D; Gil-Guillén VF; Puig-Barberà J; Fluixa C; Fernández A
    Fam Pract; 2014 Dec; 31(6):694-8. PubMed ID: 25114161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation.
    Weintraub WS; Mahoney EM; Lamy A; Culler S; Yuan Y; Caro J; Gabriel S; Yusuf S;
    J Am Coll Cardiol; 2005 Mar; 45(6):838-45. PubMed ID: 15766816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prasugrel (Effient) vs. clopidogrel (Plavix).
    Med Lett Drugs Ther; 2009 Sep; 51(1320):69-70. PubMed ID: 19738549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of cytochrome P450 2C19 genotype screening for selection of antiplatelet therapy with clopidogrel or prasugrel.
    Reese ES; Daniel Mullins C; Beitelshees AL; Onukwugha E
    Pharmacotherapy; 2012 Apr; 32(4):323-32. PubMed ID: 22461122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The "clopidogrel resistance" trap.
    Serebruany VL
    Am J Cardiol; 2007 Sep; 100(6):1044-6. PubMed ID: 17826395
    [No Abstract]   [Full Text] [Related]  

  • 39. The antiplatelet effects of ticlopidine and clopidogrel.
    Sharis PJ; Cannon CP; Loscalzo J
    Ann Intern Med; 1998 Sep; 129(5):394-405. PubMed ID: 9735068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clopidogrel: to test or not to test? That is the question--still.
    Cannon CP
    Clin Chem; 2011 May; 57(5):659-61. PubMed ID: 21402801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.